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ABSTRACT 
PURPOSE: To examine the effect of separate and combined exposure to hypoxia (normoxia (FIO2 = 
0.21) vs. moderate altitude (FIO2 = 0.13)) and temperature (thermoneutral (22°C) vs. cold (5°C)) on 
muscle fatigue development in the forearm, after repeated low resistance contractions. METHODS: 
Eight males were exposed for 70-mins to four separate conditions in a balanced order. Conditions were 
normoxic-thermoneutral (N), hypoxic-thermoneutral, normoxic-cold and hypoxic-cold. After 15-min 
seated rest, participants carried out intermittent dynamic forearm exercise at 15% maximal isometric 
voluntary contraction (MVC) for eight consecutive, 5-min work bouts. Each bout was separated by 
110-s rest during which MVC force was collected. RESULTS: When exposed to hypoxia and cold 
independently, the exercise protocol decreased MVC force of the finger flexors by 8.1 and 13.9% 
respectively, compared to thermoneutral normoxia. When hypoxia and cold were combined, the 
decrease in MVC force was 21.4% more than thermoneutral normoxia, reflecting an additive effect and 
no interaction. EMG relative to force produced during MVC, increased by 2 and 1.2 μV per kg (36 & 
23% of N) for cold and hypoxia respectively. When the stressors were combined the effect was 
additive, increasing to 3.1 μV per kg (56% of N). CONCLUSION: When compared to exercise in 
thermoneutral normoxic conditions, both cold and hypoxia significantly reduce brief MVC force 
output. This effect appears to be of mechanical origin, not a failure in muscle fibre recruitment per se. 
Additionally, the reduction in force is greater when the stressors are combined, showing an additive 
effect.  
 
INTRODUCTION 
Passive cold exposure can reduce a muscles mechanical response (e.g. power) to a given 
electrophysiological excitation or descending voluntary drive (Feretti 1992; Oksa et al., 2002). This is 
widely attributed to reductions in muscle temperature (Bergh & Ekblom 1979a) which reduces 
contractile function due to slowed intramuscular energetics and peripheral nerve conduction velocities 
(Kossler et al. 1987; Bigland Ritchie et al. 1981; Bergh, 1980; Faulkner et al. 1990; Sweitzer & Moss 
1990; Feretti 1992; De Ruiter & De Haan 2000; Allen et al 2008; Racinais & Oksa, 2010; Cahill et al. 
2011; Cè et al. 2012). Several studies report that action potential propagation, ATP hydrolysis, Ca
2+
 
handling and sensitively as well as cross-bridge force kinetics are adversely affected by lower tissue 
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temperatures (Kossler et al. 1987; Sweitzer & Moss 1990; Mucke & Heuer 1989; Feretti 1992; Oksa et 
al. 2002 Cè et al. 2012). However, the slowing of mechanical processes, as well as efferent and afferent 
nerve conduction, occur independently of exercise (present during passive cold exposure), and thus 
may even serve to attenuate metabolite production, and/ or increase central drive, during prolonged 
isometric contractions (Ray et al. 1997; Segal et al. 1986; De Ruiter & De Haan 2000; Todd et al. 
2005; Allen et al 2008; Cahill et al. 2011; Lloyd et al. 2014). Nevertheless, during dynamic exercise in 
cooled muscle (i.e. active cold exposure), significant increases in skeletal muscle fatigue are reported 
(Bergh and Ekblom 1979b; Bergh, 1980; Faulkner et al. 1990; Racinais & Oksa, 2010). This is 
predominantly due to co-activation of the agonist- antagonist pair (Oksa et al. 1997) resulting in higher 
workload for the agonist muscle (Oksa et al. 2002) thereby reducing aerobic- mechanical efficiency 
(McArdle et al, 1976). Furthermore, dynamic exercise in cold muscle is likely affected by reductions in 
muscle blood flow (Yanagisawa et al, 2007; Gregson et al, 2011), which may hinder oxygen delivery 
(Amann & Calbet, 2007) and diminish the removal metabolic by-products (Blomstrand et al. 1984).  
 
Contrary to tissue cooling, passive exposure to hypoxia does not appear to affect maximal force 
generating capacity or action potential propagation (Perrey & Rupp 2009). However, increases in 
muscle fatigue during prolonged exercise in hypoxia have been observed during both whole-body 
(Amann & Calbet 2007) and repeated contractions of isolated muscle groups (Fulco 1994; 1996; 
Katayama et al. 2007; Perrey & Rupp 2009; Millet et al. 2008; 2012; Christian et al. 2014a). The rise in 
muscle fatigue during hypoxia can be largely attributed to a shift of the relative exercise intensity, 
higher muscle fibre recruitment, and thereby increased intramuscular metabolic disturbance (Edwards 
1981; Fulco et al. 1996; Amann et al. 2006a; 2006b; 2007a; 2007b; Fulco et al. 1994, Katayama et al. 
2007; Christian et al. 2014a). Specifically, the increase in inorganic phosphate, reactive oxygen species 
and hydrogen ion production and their interference with the contractile proteins and sarcoplasmic Ca
2+
 
release mechanisms are thought to be a major factor behind the increase in muscle fatigue development 
(Haseler et al 1999; Hogan et al. 1999; Amann & Calbet 2007; Perrey & Rupp 2008). In hypoxia, 
evidence also suggests increased afferent feedback and decreased cerebral oxygenation can reduce 
voluntary drive to the muscle, exacerbating net fatigue (Amann & Dempsey 2007; Amann et al. 2006a; 
2007b; Goodall et al. 2010; Millet, 2008; 2012).  However, the relative contributions of afferent 
feedback and cerebral oxygenation, as well as the sense of effort, to changes in central drive during 
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fatiguing exercise in hypoxia remains subject to on-going investigations (Millet et al. 2008; 2012; 
Goodall et al. 2010; Amann et al., 2013; Christian et al. 2014a; Christian et al. 2014b).  
 
While much research exists on these stressors separately, ascent to altitude often constitutes of 
exposure to both hypoxia and cold stress; however the interactive effects of these stressors in 
combination are not well understood (Tipton, 2012). Studies that have examined combined hypoxic-
cold stress have focused largely on thermogenesis, skin blood flow and thermal sensitivity (Robinson 
& Haymes 1991; Johnston et al. 1996; Gautier et al. 1987, Wood 1991; Cipriano & Goldman 1975; 
Simmons et al. 2010; 2011), leaving fatigue development and human performance relatively 
unexamined (Tipton 2012). Given the potential for hypoxic-cold to severely compromise oxygen 
delivery to the active muscle - through simultaneous reductions in oxygen transport (muscle blood 
flow) and arterial oxygen content (hypoxemia) (Yanagisawa et al, 2007; Gregson et al, 2011; Amann & 
Calbet 2007) - as well as greatly increase metabolite production - through simultaneous rises in 
agonist-antagonist co-activation in the cold and type II recruitment in hypoxia (Edwards 1981; Fulco et 
al. 1996; Oksa et al., 2002; Amann et al. 2006a; 2006b; 2007a; 2007b; Fulco et al. 1994, Katayama et 
al. 2007; Christian et al. 2014a) - we sought to investigate the independent and combined (interactive) 
effects of hypoxia and cold on forearm fatigue.  
 
To investigate the interaction between hypoxia and cold on fatigue development an additive effects 
model (standard ANOVA) was used. Using the additive model, stressor (in fact all variables) 
interactions are categorised as either synergistic or antagonistic (Folt et al. 1999). Significant 
interactions suggest the effect size of one variable has been reduced (antagonistic) or accentuated 
(synergistic) by the presence (or effect) of the other, whereas additive effects are seen during net 
stressor independence i.e. no interaction. Interactions are best illustrated using variable A and B: 
 
Additive   = A & B combined = A + B individually  (1) 
Synergistic  = A & B combined > A + B individually (2) 
Antagonistic  = A & B combined < A + B individually  (3) 
Nullifying  = A & B combined = A or B individually  (4) 
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Multiplicative  = A & B combined = A x B individually  (5) 
 
Importantly, nullifying interactions (Eq. 4) are strong antagonistic interactions in which the influence 
of one variable has been entirely abolished by the presence (or effect) of the other; while multiplicative 
effects describe strong synergistic interactions (Eq. 5).  
 
To examine the interaction between hypoxia and cold on fatigue development, we quantified changes 
in the relationship between electromyogram (EMG) and maximal isometric voluntary contraction 
(MVC) force in response to low intensity, intermittent ‘gripping’ exercises. An isolated forearm model 
was used due to the importance of finger flexor function for climbing, mountaineering or those 
performing manual work at altitude, as well as due to the known exacerbation of fatigue during 
prolonged (> 4-min) low intensity (<30% MVC) isolated muscle exercise in both cold and hypoxic 
environments (e.g. Oksa et al. 2002; Perrey & Rupp 2009). It was hypothesised that 1) independent 
exposure to hypoxia or cold will induce a significant increase in post- exercise neuromuscular fatigue, 
compared to control conditions; and 2) during combined hypoxic-cold exposure, a synergistic 
interaction on fatigue will occur, with reductions in muscle blood flow (Yanagisawa et al, 2007; 
Gregson et al, 2011), and increased metabolite production (co-activation) during cold (Oksa et al., 
2002) synergistically accentuated by the reductions in oxygen delivery and higher type II muscle fibre 
activation observed in hypoxia (e.g. Amann & Calbet 2007). 
 
Keywords: cooling, hypothermia, high altitude, electromyography, combined stressors. 
 
Abbreviations: 
ANOVA: Analysis of Variance 
AU: Arbitrary Units 
C: Condition normoxic- cold  
EMG: Electromyography 
ED: extensor digitorum  
FCR: flexor carpi radialis 
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FDS: flexor digitorum superficialis 
FFT: Fast Fourier Transform  
FI: Fatigue Index 
FIO2: Fraction of Inspired Oxygen 
H: Condition hypoxic- thermoneutrality  
HC: Conditions hypoxic- cold 
HR: Heart Rate 
LDF: Laser Doppler flowmetry  
MVC: Maximal Voluntary Contraction 
N: Condition normoxic- thermoneutrality 
RMS: Root Mean Square 
RPE: Rate of Perceived Exertion 
SpO2: Peripheral Arterial Oxygen Saturation  
Tco: Core temperature 
Ta: Ambient temperature 
Tsk: Skin Temperature 
 
METHODS 
Subjects 
Eight healthy men volunteered as participants for this study. Their (mean ± SD) age was 21.9 ± 0.8 
years and Body Mass Index was 23.5 ± 1.8. Using the short International Physical Activity 
Questionnaire, a minimal activity level of 25 MET-hours per week was used when selecting volunteers. 
The average weekly exercise level was 41.5 ± 15.4 MET-hours per week. No participant was trained in 
a specific sport, but all participants were regularly participating in a range of physical activities, and 
thus appeared well accustomed to novel and strenuous exercise regimes. All participants were 
requested to abstain from caffeine, alcohol and exhaustive exercise 24 hours prior to the experiment.  
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The experimental protocol was approved by the Loughborough University Ethical Advisory 
Committee and was conducted in accordance with the World Medical Associations Declaration of 
Helsinki for medical research using human participants. All participants were given an information 
sheet that outlined the procedure, risks and requirements for the experiment. Participants provided 
written informed consent and completed a questionnaire based health screening. 
 
Experimental Protocol  
Systemic, 70-min exposures to four conditions were performed in T.I.S.S. Peak Performance (Series 
2009) Chambers at Loughborough University Environmental Ergonomic Research Centre. Participants 
were exposed once to each of four conditions; control/ normoxic- thermoneutrality (N), hypoxic- 
thermoneutrality (H), normoxic- cold (C) and hypoxic- cold (HC). Thermoneutral conditions (N, H) 
were 22°C (50% RH) ambient temperature (Ta) and subjects were dressed in shorts, a t-shirt, socks and 
trainers. In cold conditions (C, HC) Ta was 5°C (50% RH) and participants wore the same clothing, 
minus any upper body insulation (t-shirt). 5°C Ta was selected in an attempt to reduce average skin 
temperature (Tsk) by approximately 5-10°C, which in turn was assumed to change forearm muscle 
temperature and cause an increase in fatigue (Oksa et al. 2002) when compared to thermoneutral 
conditions (N, H). Hypoxic exposures (H, HC) were 0.13 Fraction of Inspired Oxygen (F IO2: 
equivalent attitude = ~4000m) aiming to reduce peripheral arterial oxygen saturation (SpO2) to 
approximately 85%, a moderate level assumed high enough to influence fatigue during isolated muscle 
exercise (Millet et al. 2008; 2012; Perrey & Rupp 2009; Christian et al. 2014a). The selection of 
temperature and FIO2 also aimed to balance severity with ecological validity, in order to maintain 
relevance for those working or exercising at altitude. Normobaric hypoxia was achieved using an 
inbuilt chamber hypoxic air generator. Hypoxia was continuously monitored for consistency using a 
Servomex (570A, Sussex, UK) oxygen analyser as well as the inbuilt analyser on the T.I.S.S. Peak 
Performance (Series 2009) Chambers. Condition order was balanced and exposures were separated by 
at least 4 days to allow full recovery from the fatigue protocol. Participants were blinded to conditions 
prior to exposure.  
 
Measurements of Temperature, Arterial O2 Saturation, Skin Blood Flow, Heart Rate and 
Perceived Exertion 
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During all conditions aural (Tco) and local skin temperature (Tsk) from 4 different sites on the 
exercising arm (bicep, midline of the posterior forearm, midline of the anterior forearm & posterior of 
hand), were collected. Grant International skin and aural thermistors were secured using Transpore 3M 
medical grade tape. Aural thermistors were also insulated using cotton wool and earmuffs. Data was 
recorded at 1-min intervals from 1-min pre-exposure using a Squirrel Data Logger (1000 series, Grant 
Instruments, UK). 
 
Immediately after each MVC was performed, percentage saturation of peripheral arterial blood (SpO2) 
and heart rate (HR) were measured using a pulse oximeter attached to the middle finger of the non-
exercising arm (Model 8500, Nonin Medical, Netherlands). HR and SpO2 were collected once every 5-
s over the first 20-s of each 110-s rest period. Baseline measures of resting HR and SpO2 were 
collected pre-exposure to condition N, post 5-mins supine rest. 
 
Laser Doppler flowmetry (LDF; arbitrary perfusion units [AU; Flux]) of the index finger on the non-
exercising hand (Server, Satellite and Optic Probe, MoorLAB, Moor Instruments, UK) and Borg’s Rate 
of Perceived Exertion (RPE) scores were also recorded immediately after each MVC was performed. 
LDF was calibrated prior to exposure using the Brownian motion of polystyrene microspheres diluted 
in water. This LDF device has been used in previous physiological studies to assess skin blood flow 
(Thompson, Holowatz & Kenney 2005) and is precise to ± 3% and accurate to ± 10AU as determined 
by the manufacturer (Moor Instruments, 2004). 
 
Fatigue Protocol & Force Measurement 
Upon exposure to the test conditions, each participant was secured into a restraint system that 
maintained 90° flexion of the elbow, with the palm and anterior forearm facing vertically, while 
restricting any movement of the wrist. The system was used to isolate the working forearm muscles 
and maintain consistent muscle dynamics during exercise. Participants remained secured throughout 
the experiment. Once in the environmental conditions, participants undertook a 15-min rest period, 
allowing time for body heat to decline in cold (not reaching steady state) and arterial oxygenation to 
stabilise in hypoxia. After the rest period, participants performed a fatigue protocol that consisted of 
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eight 5-min work bouts, each separated by 110-s rest/ data collection periods, timed using a standard 
digital stopwatch. During each 5-min exercise bout, dynamic grip clenches (Fit66 Adjustable Grip 
Exerciser) were performed every 2-s (timed using an audio/visual metronome), at a workload of 15% 
of the MVC recorded at the start of the exposure (MVCbaseline) on their first experimental day. Given all 
subjects were healthy, regularly active, and accustomed to performing a wide range of physical 
activities, no separate familiarisation was deemed necessary; however to ensure an accurate prediction 
of workload was made, practise attempts were available during the MVC used to predict the workload. 
In all other circumstances, only one MVC was performed.  Based on pilot studies, the fatigue protocol 
was designed to induce an estimated workload that was approximately equal to or greater than, ‘hard’ 
or 15 on Borg's RPE Scale, when conducted in thermoneutral normoxic conditions. 
 
MVC force (3-s contraction) using a Grip Dynamometer (Takei™ No.1857) was collected at the start 
of each exposure (MVCbaseline) and after every second work bout (MVC1, MVC2, MVC3, MVC4). A 
change in MVC, in conjunction with the corresponding EMG data was used to quantify fatigue.  
Baseline measures of EMG (EMGbaseline) and MVC were collected on immediate exposure to the 
experimental condition. A schematic overview of the experimental protocol and interventions is shown 
in Figure 1. 
 
Electromyography & Fatigue Index 
To evaluate the myoelectrical activity of the working muscles, surface EMG (Biometrics Ltd, UK) was 
measured on flexor carpi radialis (FCR), flexor digitorum superficialis (FDS) and extensor digitorum 
(ED).  Other studies analysing forearm muscle fatigue have utilised similar muscle groups (West et al. 
1995; Oksa et al. 2002).  Flexor group (FCR & FDS) contractions were dynamic during grip clench 
exercises, and isometric during MVC. The extensor digitorum acts as a fixator and was isometric 
during both contraction manoeuvres.  
 
The placement of each electrode sensor followed the recommendations outlined by SENIAM (Hermens 
et al., 1999). The skin was cleaned with alcohol and shaved when necessary. To ensure accurate 
placement, participants were positioned with the hand supinated and elbow flexed (FDS and FCR) or 
with the hand pronated and the elbow extended (ED). Each electrode (Biometric Ltd EMG pre 
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amplifier type no.SX230) was placed over the belly of the muscle, identified using palpation over the 
centre line between the origin and insertion of the muscle. Finger and grip movements were used to 
tense the appropriate muscle, inducing visible muscle tone, and aiding the accuracy and consistency of 
EMG placement. The placement of the FDS (1), the FCR (2) and ED (3) electrodes anatomically 
corresponded to: 1) 2/3 medial of the lateral border of the ventral forearm (in line with the 2
nd
 middle 
phalanx) and 2/3 distal from antecubital fossa to the wrist- palm intersection; 2) medial of the lateral 
border of the ventral forearm (in line with the 1
st
 middle phalanx) and 1/3 distal from the antecubital 
fossa to wrist- palm intersection; and finally 3) one half medial of the lateral border of the dorsal 
forearm (in line with the 2
nd
 middle phalanx) and 1/3 distal from the line of the antecubital fossa to the 
ulna styloid process. All sensors and wires were secured using double sided tape with the two 2-cm 
spaced probe contacts running in parallel with the muscle fibres. The reference/ ground electrode 
(Biometrics Ltd earthing strap type no.R200) was placed above the ulna styloid process (inactive 
tissue) on the opposite wrist. All signals were zeroed prior to measurement and MVC data was logged 
on a DataLog P3X8 (Biometrics Ltd, UK).  
 
EMG was recorded during all MVC measurements. The EMG sample rate used was 1000Hz, and was 
amplified 1000 times to minimise noise on the connecting cable. A signal band of 15Hz to 450Hz, 
minus the unwanted line frequency of 50 or 60Hz, including the harmonics of this frequency, was 
measured. Root Mean Square (RMS; μV) amplitude values were averaged over a 400-ms running 
average for the duration of the MVC. Analysis was carried out on the corresponding DataLog Software 
(Biometrics Ltd, UK) then confirmed and stored using Microsoft Excel 2007. For EMG analysis, a 1-s 
manually selected sample to include the steadiest values either side of the highest point in the EMG 
signal was used. Each muscle EMGrms amplitude was calculated using the mean over each 1-s trace. To 
calculate the average combined muscles EMGrms amplitude, FDS FCR and ED were weighted as 1:1:2 
representing a value equal in its contributions from flexors and extensors compartments. 
 
The variable used in this study to define the level of mechanical fatigue was the Fatigue Index (FI; 
Oksa et al. 2002). The FI quantifies fatigue using changes in MVC force and EMG amplitude of both 
the flexor and extensor muscles (mean flexor and extensor weighted 1:1; see above), relative to start 
and finish of the exercise protocol. FI is calculated as: 
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FI = (MVCbaseline / EMGbaseline) / (MVC4 / EMG4)  
 
If FI = 1.0 then fatigue is not apparent, however the higher the value above 1.0, the greater the 
mechanical failure (force independent of excitation). FI differed in the present study from Oksa et al. 
(2002), because EMG data was collected during the MVC manoeuvre, not during submaximal 
(fatiguing) exercise; although FI in this case still represents electromechanical transmission failure as 
well as fatigue though intramuscular metabolic disturbance of the mechanical contraction. To represent 
the electromechanical ratio over time, EMGrms relative to force produced during MVC (μV per kg) was 
used; this variable is analogous to FI. 
 
Data analysis 
Independent variables for this study were 1) FIO2; 2) Ta; and 3) experimental time. Dependent 
Variables were MVC, EMGrms amplitude, RPE, HR, LDF flux, Tco, Tsk, and FI. All LDF data were 
corrected for individuals occluded baseline value using a 2- min-vascular occlusion (rubber band 
applied to the finger base) during the 15-min rest-period in condition N. MVC and EMG were 
calculated to represent a change from baseline for each condition. In the figures, EMG data and FI 
were normalised to the control condition. The following calculation was used to express the variables 
in condition H, C, and HC, as a percentage change from condition N: 
 
Normalised change (%) = (Treatment [H, C, HC] / Control [N]) – 1) x 100 
 
Significance between conditions across the whole exposure was tested using a three-way [2 x 2 x 5; 
FIO2 x Ta x time (fatigue)], repeated measures ANOVA. Significance was tested at a 95% confidence 
level (p, <0.05).  To test FI and specific time point data for significance between FIO2 and Ta, two-way 
(2 x 2) repeated measures ANOVA was used. When no significant interaction was observed, the effect 
of cold and hypoxia were reported as C & HC collapsed or H & HC collapsed respectively.  All results 
are displayed as mean ± SEM.   
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RESULTS 
Temperature, Arterial O2 Saturation, Skin Blood Flow, Rate of Perceived Exertion & Heart Rate 
Table 1 shows body temperature, SpO2, Skin Blood Flow, RPE & HR across conditions at each MVC 
intervention. A significant (p = 0.001) reduction in pre-exposure to MVC4 ∆Tco was observed during 
cold conditions (-0.46 ± 0.18°C) whereas a significant increase (p = 0.007) in ∆Tco was observed in 
thermoneutral conditions (0.19 ± 0.05°C). The results showed a significant effect of cold Ta (p = 0.003) 
but no significant effect of hypoxia (p = 0.6) and no interaction (p = 0.5) between stressors.  At 
MVC4Tsk of the posterior and anterior forearm was also significantly (p < 0.05) lower during cold 
exposures (25.6 ± 0.5°C) than thermoneutral (32.7 ± 0.3°C), therefore achieving the aimed reduction in 
local Tsk of 5-10°C. Forearm Tsk increased slightly at exercise commencement (t = 15-mins) in all 
conditions but remained significantly (p < 0.05) lower in cold. Mean skin blood flow (LDF flux) over 
all time points was also significantly (p = 0.001) lower in the cold (-178 ± 63 AU). HR varied similarly 
with temperature (p = 0.03), reducing from 85 ± 2 bpm in thermoneutral conditions to 78 ± 2 bpm in 
cold. We observed no significant effects of hypoxia on forearm Tsk (p = 0.8), HR (p = 0.2) or LDF flux 
(p = 0.3). Mean SpO2 measurements across the four interventions showed a significant (p = 0.001) 
reduction from 97.5 ± 0.3% SpO2 in normoxic conditions to 85.5 ± 0.6% SpO2 in hypoxic conditions. 
While the effect of temperature on SpO2 was significant (p= 0.01) the mean change was minimal 
(~1%).  
 
RPE increased significantly (p = 0.03) over time (RPE first set 12.6 ± 0.7; RPE last set 14.0 ± 0.7) but 
no participants reached task failure during the fatigue protocol in any conditions. There was no main 
effect over time for temperature (p = 0.4) and hypoxia (p = 0.1). However, a significant effect of 
temperature was observed at MVC3 (p = 0.021) and MVC4 (p= 0.014) and a trend for the effect of 
hypoxia (p = 0.074) was observed at MVC1 (Table 1). 
 
Maximal Isometric Voluntary Contraction 
Figure 2 shows MVC force produced at each intervention in each condition. MVC decreased 
significantly (p <0.05) over time and varied significantly (p <0.05) between conditions at various MVC 
time points (see Figure 2). However, when combined there was no significant statistical interaction 
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between cold and hypoxia (independent contributions) on the total decrease at MVC4 (p = 0.8) or at the 
MVC time points i.e. the combined effect of cold and hypoxia was additive. Figure 2, Panel B also 
shows MVC plotted as a percentage decline from the baseline MVC.  
 
Electromyography & Fatigue Index. 
EMGrms amplitude during MVC for the combined forearm muscles decreased incrementally with time 
(p = 0.03), however the effects of temperature (p > 0.2) and hypoxia (p > 0.5) were not significant 
between interventions (Figure 3, Panel A), except during MVC1 where the normalised combined 
EMGrms was higher (p = 0.05) during cold conditions (C + HC) by 32 ± 13 μV (Figure 3, Panel B).  
 
The FI of the forearm muscles increased to 1.25 in cold and 1.10 in hypoxia. Variance was significant 
for effects of temperature (p= 0.003) and hypoxia (p = 0.01) however there was no stressor interaction 
(p = 0.9): FI was equal 1.45 in combined conditions (Figure 4, Panel A). Expressed as a percentage of 
condition N (FI%), exercise resulted in 24 ± 7% and 39 ± 9% higher fatigue in hypoxia and cold 
respectively. The combined effect was additive resulting in 62 ± 11% increase in FI i.e. there was no 
interaction (Figure 4, Panel B; Table 1). EMGrms relative to force produced during MVC (μV per kg) 
was also significantly increased, with main effects for cold (p = 0.02) over time and a strong trend for 
hypoxia (p = 0.06) over time. By MVC4 the effect was significant for both cold (p = 0.003) and 
hypoxia (p = 0.008), increasing by 2.0 and 1.2 μV per kg (36 and 23% of condition N) respectively. 
The combined effect was additive (3.1 μV per kg and 56% of condition N) showing no interaction (p = 
0.9) between stressors (Figure. 5, Panel A).  
 
DISCUSSION 
Summary of main findings 
This study quantified forearm muscle fatigue development during independent and combined 
reductions in ambient temperature and inspired oxygen concentration, during repeated low resistance 
exercise. The results demonstrate an additive, not interactive, effect on fatigue when humans are 
exposed to combined hypoxia and cold. Additive effects were observed for both MVC force output and 
electromechanical ratio (FI and μV per kg) at various time points. 
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Maximal voluntary contraction in hypoxic -cold  
The decline in maximal voluntary force over time can be used to quantify net (overall) neuromuscular 
fatigue (Gandevia, 2001).  
 
In this study, independent exposure to hypoxia and cold significantly reduced MVC force at various 
time points (Figure 2). In hypoxia, the decline in MVC force (Figure 2, Panel B) occurred early in the 
fatigue protocol, before plateauing at a lower level than thermoneutral normoxic conditions (Figure 2, 
Panel B). This differed from cold stress, which continuously reduced MVC over time, resulting in a 
greater impact of cooling [compared to hypoxia] in the later stages of the exercise protocol (Figure 2, 
Panel B). The differences in the temporal decline in MVC may be explained by the stabilisation of 
arterial oxygenation early in the hypoxic protocol (Table 1), contrary to a more progressive cold 
penetration through peripheral tissue with cold exposure.  
 
When hypoxia and cold were combined, the temporal (shape of) decline in MVC force (Figure 2, Panel 
B) reflected equal (additive) contributions from both stressors, with neither hypoxia nor cold taking 
clear precedence in the combined condition (Figure 2, Panel B) i.e. during hypoxic-cold, MVC was 
subject to both an early (hypoxic) and progressive (cold) decrease over time. This is reflected in the 
final MVC (MVC4), which reduced in force to a value equal to the summative effect of each stressor 
individually. Specifically during independent cold and hypoxic stress, MVC force declined by 8.1 and 
13.9% more than thermoneutral normoxia, while MVC force decreased by 21.4% more during 
combined hypoxic-cold, closely matching the additive value of hypoxia and cold individually (22%). 
 
Electromechanical mechanisms during fatigue  
Force and EMG assessment has been widely used to understand central and peripheral contributions to 
fatigue (for reviews see: Gandevia, 2001 Amann & Calbet 2007). However EMG is perhaps better 
suited to subdividing electrophysiological excitation and mechanical fatigue further downstream from 
the neuromuscular junction – to a point within the muscle fibre itself (Allen et al. 2008). Importantly 
under this definition, mechanical fatigue still encompasses many of the intramuscular factors usually 
associated with peripheral fatigue (Enoka & Stuart 1992; Fitts 1994; Allen et al 2008), while the 
15 
 
changes in motor unit excitation remain partially representative of descending voluntary drive 
(Gandevia, 2001).  
 
Mechanical fatigue in hypoxic-cold 
In the present study, mechanical fatigue was disassociated from electrophysiological changes using the 
electromechanical ratio. These include EMGrms relative to MVC force (in μV per kg) and the FI (Figure 
4; Figure 5). EMG/MVC and the FI measure the direct mechanical response to net fibre excitation and 
can be attributed on an individual fibre basis to both electromechanical transmission failure and a 
reduced mechanical response (e.g. force or power) per unit of excitation (Allen et al. 2008).  
 
 In this study, independent cold exposure resulted in an increase in both ∆EMG/MVC and the FI 
(Figure 4; Figure 5). A similar yet smaller effect was observed during independent exposure to 
hypoxia. By MVC4 (post-exercise), ∆EMG/MVC was significantly increased by 1.2 and 2 μV per kg in 
hypoxia and cold respectively, representing a 23 and 36% change from N (Figure 5). This 
corresponded to a 24 and 39% increase in FI respectively (Figure 4). FI and ∆EMG/MVC reflected the 
effect of hypoxia and cold on MVC force (Figure 2), suggesting fatigue was predominantly of 
mechanical origin in this study i.e. a failure distal of electrophysiological processes. This is supported 
by the time course of mechanical fatigue, which is similar to those observed in electrically stimulated 
muscle fibres in vitro; an early increase, a plateau, then a late increase (Allen et al 2008; Marcora & 
Staiano, 2010). 
 
Mechanical failure independent of excitation during cold exposure can be attributed to number of 
factors, such as increases in the relative exercise intensity due to co-activation of the agonist- 
antagonist pair (Oksa et al. 1997; 2002; Racinais & Oksa 2010) and reduced muscle blood flow 
(Yanagisawa et al, 2007; Gregson et al, 2011). It may also result from progressive cold penetration 
through the muscle tissue (Oksa et al. 2002) gradually increasing the number of muscle fibres affected 
by slowed intramuscular energetics (Bergh, 1980; Faulkner et al. 1990; De Ruiter & De Haan 2000; 
Allen et al 2008; Racinais & Oksa, 2010; Cahill et al. 2011). Conversely, the mild effect of hypoxia on 
mechanical function (fatigue) has been widely attributed to increases in energetic metabolite 
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interference with Ca
2+
 handling and the contractile proteins (Edwards 1981; Fulco et al. 1996; Fitts 
1994; Haseler et al. 1999; Hogan et al. 1999; Amann & Calbet 2007; Perrey & Rupp 2009; Christian et 
al., 2014a).   
 
In this study, it was hypothesised that during combined hypoxic-cold stress, co-activation (Oksa et al. 
2002) and muscle blood flow reductions (Yanagisawa et al, 2007; Gregson et al, 2011) in cold would 
accentuate the low oxygen delivery (Amann & Calbet 2007) during hypoxia, resulting in an interaction 
on net fatigue (MVC) due to altered function at the mechanical level (FI and ∆EMG/MVC).  However, 
contrary to this hypothesis the effect on mechanical fatigue was additive showing no interactions; 3.1 ± 
0.3 μV per kg (FI increased by 62% of N) (Figure 4; Figure 5). One explanation for this is that the 
inhibitory influence of increased energetic metabolites during hypoxia (Fitts 1994; Haseler et al. 1999; 
Hogan et al. 1999; Perrey & Rupp 2009), was not influenced by the direct slowing effect of cooling on 
ATP hydrolysis, Ca
2+
 handling and the contractile proteins during cold exposure (Kossler et al. 1987; 
Sweitzer & Moss 1990; Feretti 1992; Oksa et al. 2002). It suggests that despite each stressor hindering 
mechanical function, cold and hypoxia may influence fatigue through sufficiently independent cellular 
mechanisms, so as not to interact with one another during low resistance exercise.  
 
The observed additive effect may also result from multiple inter-mechanism interactions and/or an 
interaction cancelation. A synergistic and antagonistic interaction of similar magnitude would result in 
net additive effects, and thus to investigate this further, interactive studies examining the individual 
mechanisms that contribute to hypoxic- cold fatigue are required. 
 
Electrophysiological factors during fatigue in hypoxic- cold 
In the present study, MVC sequentially decreased in peak force output and EMGrms amplitude over 
time, across all conditions (Figure 3). This suggests changes in corticospinal drive (Gandevia, 2001) 
and/ or action potential propagation (Bigland Ritchie et al. 1981) were partially responsible for fatigue 
observed during the exercise protocol. However, the decline in combined forearm EMGrms was not 
generally affected by condition, thus it is unlikely that electrophysiological factors are primarily 
responsible for the environmental influences on fatigue in the present study. Moreover, despite changes 
in cognitive function as a result of immediate exposure to environmental stress (Gaoua et al. 2011), we 
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observed no influence on MVC or EMGrms at the start of the exposure, suggesting central drive and 
muscle fibre recruitment remained largely unaffected.  
 
Perceptual responses to fatigue in hypoxic- cold  
Despite no significant condition effect on motor unit recruitment (EMGrms) during MVC (Figure 3), the 
rise in the relative work rate (recruitment/ voluntary drive) during submaximal repetitive exercise over 
time and across conditions did appear to mildly increase RPE (Table 1). RPE reflected the temporal 
decline in overall fatigue, showing a trend for decrease early in hypoxia (MVC1) and a small effect on 
effort during the latter stages of the protocol with cooling (MVC3 & MVC4). Since participants 
received no specific detailing on the interpretation of RPE, the increase is likely in response to both a 
greater mental effort (Marcora & Staiano, 2010) and a higher peripheral discomfort (Christian et al. 
2014b) with fatigue.  
 
The effect on mechanical and perceived fatigue, yet not MVC recruitment could be because of the 
inherent limitations on conscious regulation during closed loop protocols. In this study, the only option 
was to a) stop exercise, or b) attenuate motor output during a brief MVC; each providing little or no 
relief from fatigue. As such, neither perceptual tolerance to fatigue, nor the volitional regulation of 
neural drive in response to high or maximal levels of peripheral fatigue were investigated. In fact, even 
given a greater scope for regulation, recovery between bouts may have resulted in maintained neural 
drive during brief maximal contractions, since afferent feedback is most relevant during a prolonged 
mental effort with no immediate recovery (Cahill et al., 2011; Amann et al. 2013; Christian et al. 
2014a
;
 Lloyd et al., 2014). 
 
Additional perspectives and limitations 
Previous studies have shown that hypoxia can cause vasodilation in non- acral skin during cold 
exposure (e.g. Cipriano & Goldman, 1975; Johnston et al. 1996; Simmons et al, 2010). However, the 
vasoconstrictor response of acral skin (finger pad) during cold exposure was not significantly affected 
by hypoxia in the present study. A possible explanation is that the large core to skin temperature 
gradient (~ -11°C) at the non- exercised finger was sufficient to abolish the hypoxic vasodilation effect 
(Simmons et al, 2011), contrary to observations of more proximal skin at milder temperatures for 
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shorter durations (Cipriano & Goldman, 1975; Simmons et al, 2010). Furthermore, to our knowledge 
no direct relationship has previously been shown between perfusion of skin microvasculature and local 
muscle blood flow. As such, substantiation of the link between skin, local muscle blood flow, and 
fatigue during both local cold, and combined hypoxic- cold stress, would be an interesting avenue for 
future studies.  
 
In the present study aural temperature was used to illustrate changes in core temperature. The results 
showed a small but significant shift of -0.46°C during cold exposure, despite a probable increase in 
metabolic rate during exercise. It should be noted that some of this drop in aural temperature may have 
been caused by local tissue cooling of the aural canal in this study. However previous studies using a 
similar duration and severity of hypoxic- cold have reported similar changes after 75-mins rest 
measured by rectal temperature (-0.4°C; Robinson & Haymes 1990) and a follow up study in our lab 
under similar conditions as the present study (using rectal temperature assessment) has also produced 
drops in core temperature, although smaller (-0.2°C after 40-min rest) and after an initial rise (0.15°C). 
 
Surface EMG reflects not only descending drive to the muscle but also the electrode/ muscle interface. 
As such the effect of changes in local tissue temperature around electrode site cannot be ruled out as a 
contributing factor to the present observations (Racinais, 2013).  Also, because flexor and extensor 
EMG was not measured during the submaximal exercise bouts, co-activation and the temporal rise in 
mechanical fatigue cannot be concluded from the present results. Additionally due to the use of small 
forearm muscles in this study, inter-muscle cross talk is a potential limitation. Finally, it should be 
recognised that the absence of a separate familiarisation for MVC trials is also a limitation. While this 
may be minimised by allowing practise attempts prior to the prediction of workloads, and by using 
young, regular exercisers who are well accustomed to physical activity, the importance of this on 
reproducibility, validity and reliability should be acknowledged in the context of this study. 
 
 
Conclusion 
In conclusion, the decrease in MVC force and increase in electromechanical ratio and FI (Figures 2, 4 
& 5 respectively) support previous findings, suggesting that independent exposure to cold and hypoxia 
can significantly increase muscle fatigue compared to control conditions. The main finding of this 
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study is that when moderate hypoxia and cold exposure are combined, the decline in MVC force and 
rise in electromechanical ratio suggest the level of fatigue increases additively, with no interactions; 
however further research is warranted using alternative stressor severities and exercise modalities, as 
this may lead to different results.  
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TABLE LEGENDS 
Table 1: The effect of condition and time on aural temperature (Tco), whole arm and forearm skin 
temperature (Tsk), heart rate (HR), peripheral arterial oxygen saturation (SpO2), index finger blood flow 
(LDF), and rate of perceived exertion (RPE). Temperature data are averaged over each 110-s rest 
period. HR, SpO2 and LDF are averaged over 20-s after each MVC. N, thermoneutral (22°C Ta) 
normoxic (0.21 FIO2); H, thermoneutral (22°C Ta) hypoxic (0.13 FIO2); C, cold (5°C Ta) normoxic 
(0.21 FIO2); HC, cold (5°C Ta) hypoxic (0.13 FIO2). Symbols for effects within the same time point: 
@
Trend for effects of hypoxia (p <0.08). *Significant for effects of temperature (p <0.05); 
#
Significant 
for effects of FIO2 (p <0.05). 
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FIGURE LEGENDS 
Fig 1 Schematic representation of the experimental protocol, measurements taken and interventions. 
Tco, aural temperature; Tsk, skin temperature; MVC, maximal isometric voluntary contraction; EMG, 
electromyography; LDF, laser Doppler blood flow; SpO2,  peripheral oxygen saturation percentage; 
HR, heart rate; RPE, rating of perceived exertion. Straight arrows indicate the timing of data collection 
interventions. 
Fig 2 The effect of fatigue on maximal voluntary contraction (MVC) across conditions. Panel B shows 
maximal voluntary contraction force normalised to baseline for each intervention. N, thermoneutral 
(22°C Ta) normoxic (0.21 FIO2); H, thermoneutral (22°C Ta) hypoxic (0.13 FIO2); C, cold (5°C Ta) 
normoxic (0.21 FIO2); HC, cold (5°C Ta) hypoxic (0.13 FIO2). Symbols for effects within the same time 
point: *Significant for the effect of temperature to p <0.05 level. 
#
Significant for the effect of FIO2 to p 
<0.05 level. 
Fig 3 The effect of fatigue on root mean squared electromyogram amplitude (EMG) across conditions. 
Panel B shows EMGrms normalised to baseline for each intervention. N, thermoneutral (22°C Ta) 
normoxic (0.21 FIO2); H, thermoneutral (22°C Ta) hypoxic (0.13 FIO2); C, cold (5°C Ta) normoxic 
(0.21 FIO2); HC, cold (5°C Ta) hypoxic (0.13 FIO2). Symbols for effects within the same time point: 
*Significant for the effect of temperature to p <0.05 level (data significant when normalised percentage 
of baseline only). 
Fig 4 The effect of condition on Fatigue Index (Panel A) and conditon normalised (∆) Fatigue index 
(Panel B); N, thermoneutral (22°C Ta) normoxic (0.21 FIO2); H, thermoneutral (22°C Ta) hypoxic (0.13 
FIO2); C, cold (5°C Ta) normoxic (0.21 FIO2); HC, cold (5°C Ta) hypoxic (0.13 FIO2). *Significant for 
the effect of temperature to p <0.005 level. 
#
Significant for the effect of FIO2 to p <0.05 level. 
Fig 5 shows the EMG/MVC relative to baseline, and normalised to the thermoneutral condition for 
each time point in hypoxia (H), cold (C) and hypoxic- cold (HC). The right hand axis on both panels 
shows each variable as percentage change of thermonuertral normoxic condition. Symbols for effects 
within the same time point: 
@
Trend for effects of temperature (p <0.08). *Significant for effects of 
temperature (p <0.05); **Significant for effects of temperature (p <0.01). 
+
Trend for effects of FIO2 (p 
<0.08). 
#
Significant for effects of FIO2 (p <0.05); 
##
Significant for effects of FIO2 (p <0.01). 
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Table1: 
 
Variable Time Point N H C HC 
Aural T
co 
(°C) 
Pre-exposure 36.45 ± 0.08 36.38 ± 0.07 36.60 ± 0.12 36.57 ± 0.07 
iMVC
1 
(∆T
co
) 0.20 ± 0.06 0.21 ± 0.09 0.07 ± 0.20 -0.10 ± 0.11 
iMVC
2  
(∆T
co
) 0.20 ± 0.06 0.21 ± 0.08 -0.08 ± 0.23* -0.31 ± 0.14* 
iMVC
3  
(∆T
co
) 0.18 ± 0.05 0.19 ± 0.08 -0.23 ± 0.24* -0.45 ± 0.16* 
iMVC
4  
(∆T
co
) 0.18 ± 0.05 0.21 ± 0.08 -0.33  ± 0.25* -0.58  ± 0.17* 
Whole Arm T
sk 
(°C) 
Pre-exposure 30.66 ± 0.56 30.99 ± 0.36 32.03 ± 0.18 31.30 ± 0.24 
iMVC
1
 32.40 ± 0.39 32.29 ± 0.28 24.70 ± 0.56* 25.06 ± 0.81* 
iMVC
2
 32.76 ± 0.37 32.53 ± 0.26 24.90 ± 0.47* 25.13 ± 0.78* 
iMVC
3
 32.89 ± 0.35 32.53 ± 0.30 24.94 ± 0.53* 25.35 ± 0.72* 
iMVC
4
 32.86 ± 0.32 32.50 ± 0.25 24.86 ± 0.52* 25.08 ± 0.62* 
Forearm T
sk 
(°C) 
Pre-exposure 30.53 ± 0.46 30.62 ± 0.31 32.06 ± 0.22* 31.17 ± 0.38 
iMVC
1
 32.48 ± 0.36 32.20 ± 0.42 25.10 ± 0.73* 25.69 ± 0.93* 
iMVC
2
 33.06 ± 0.29 32.73 ± 0.39 25.68 ± 0.72* 26.27 ± 0.89* 
iMVC
3
 33.20 ± 0.26 32.80 ± 0.46 26.08 ± 0.79* 26.42 ± 0.88* 
iMVC
4
 33.17 ± 0.24 32.76 ± 0.36 26.08 ± 0.63* 26.35 ± 0.82* 
HR (BPM) 
Pre-exposure 61.5 ± 1.0 - - - 
iMVC
baseline
 87.4 ± 4.7 85.3 ± 2.5 77.3 ± 3.6* 79.3 ± 4.4* 
iMVC
1
 81.6 ± 1.8 89.0 ± 3.2@ 77.0 ± 3.7* 81.4 ± 3.3*@ 
iMVC
2
 81.6 ± 2.5 82.0 ± 4.0 78.1 ± 4.0 78.9 ± 2.4 
iMVC
3
 84.6 ± 3.1 90.4 ± 4.0# 75.1 ± 4.0* 81.3 ± 3.4*# 
iMVC
4
 85.8 ± 2.9 87.8 ± 4.1 76.8 ± 3.1* 80.5 ± 4.3* 
SpO
2
(%) 
Pre-exposure 98.0 ± 0.4 - - - 
iMVC
baseline
 96.8  ± 0.3 87.4  ± 1.5# 97.9 ± 0.5 88.6 ± 0.9# 
iMVC
1
 97.4  ± 0.3  85.3 ± 0.6# 98.1 ± 0.3 86.6 ± 1.2# 
iMVC
2
 97.0 ± 0.4 85.0 ± 0.7# 98.5 ± 0.2 87.0 ± 1.6# 
iMVC
3
 96.6 ± 0.5 83.9 ± 1.3# 98.5 ± 0.4* 84.8 ± 0.6*# 
iMVC
4
 97.5 ± 0.4 83.9 ± 0.9# 98.3 ± 0.3* 86.0 ± 0.8*# 
LDF (% of N) 
iMVC
baseline
 389 ±14 408 ± 53 199 ± 25* 172 ± 27* 
iMVC
1
 345 ± 51 303 ± 47 76 ± 17* 65 ± 15* 
iMVC
2
 304 ± 46 256 ± 66 98 ± 19* 77 ± 20* 
iMVC
3
 317 ± 53 253 ± 68 84 ± 23* 96 ± 22* 
iMVC
4
 268 ± 44 272 ± 47 42 ± 12* 94 ± 25* 
RPE 
iMVC
1
 12.4 ± 0.8 13.4 ± 0.8@ 11.9 ± 1.0 12.8 ± 0.7@ 
iMVC
2
 12.5 ± 0.9 13.6 ± 0.6 13.0 ± 0.7 12.9 ± 0.8 
iMVC
3
 13.0 ± 0.8 14.0 ± 0.7 13.9 ± 0.6* 14.0 ± 0.8* 
iMVC
4
 13.1 ± 0.9 14.0 ± 0.7 14.0 ± 0.8* 14.8 ± 0.6* 
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